Total Visits

Views
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial37

Total Visits Per Month

February 2022March 2022April 2022May 2022June 2022July 2022August 2022
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial00027730

File Visits

Views
neurology_a2022v9n3.pdf14

Top country views

Views
United States16
China3
Spain3
Ireland2
Netherlands1
Russia1
Sweden1
Slovenia1

Top cities views

Views
Chicago6
Secaucus3
Fairfield2
Houston2
Ann Arbor1
Beijing1
Concord1
Ljubljana1
Moscow1
Woodbridge1